Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Geriatrics
Published in: BMC Geriatrics 1/2013

Open Access 01-12-2013 | Research article

Cross-sectional associations between prevalent vertebral fracture and pulmonary function in the sixth Tromsø study

Authors: Bente Morseth, Hasse Melbye, Svanhild Waterloo, Marte R Thomassen, Marijke J Risberg, Nina Emaus

Published in: BMC Geriatrics | Issue 1/2013

Login to get access

Abstract

Background

Persons with vertebral fracture may have reduced pulmonary function, but this association has not been much studied. The aim of this cross-sectional study was therefore to examine the relationship between vertebral fracture and pulmonary function in a general, elderly population.

Methods

Vertebral morphometry was used for vertebral fracture assessment in 2132 elderly men (n = 892) and women (n = 1240) aged 55 to 87 years in the population-based Tromsø Study 2007–08. Pulmonary function was examined by spirometry. Pulmonary function was expressed as FVC% predicted, FEV1% predicted, and FEV1/FVC% predicted values, adjusted FVC, FEV1, and FEV1/FVC, and obstructive and restrictive ventilatory impairment. Vertebral fracture was classified according to appearance, number, severity, and location of fractures. Associations were analyzed using general linear and logistic models.

Results

FVC% predicted and FEV1% predicted values were not associated with vertebral fracture (P > 0.05), whereas FEV1/FVC% predicted ratio was associated with both prevalent fracture, number of fractures, severity of fractures, and fracture site in men (P < 0.05), but not in women. When FVC, FEV1, and FEV1/FVC values were adjusted for multiple covariates, we found no significant association with vertebral fracture. Obstructive and restrictive ventilatory impairment was not associated with prevalent vertebral fracture.

Conclusions

In conclusion, this study did not confirm any clinically relevant associations between prevalent vertebral fracture and ventilatory impairment in elderly individuals.
Appendix
Available only for authorised users
Literature
1.
Ahmed LA, Schirmer H, Bjørnerem A, Emaus N, Jørgensen L, Størmer J, Joakimsen RM: The gender- and age-specific 10-year and lifetime absolute fracture risk in Tromsø Norway. Eur J Epidemiol. 2009, 24 (8): 441-448.CrossRefPubMed
2.
Johnell O, Kanis J: Epidemiology of osteoporotic fractures. Osteoporos Int. 2005, 16 (Suppl 2): S3-S7.CrossRefPubMed
3.
Cummings SR, Melton LJ: Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002, 359 (9319): 1761-1767.CrossRefPubMed
4.
Lofthus CM, Osnes EK, Falch JA, Kaastad TS, Kristiansen IS, Nordsletten L, Stensvold I, Meyer HE: Epidemiology of hip fractures in Oslo Norway. Bone. 2001, 29 (5): 413-418.CrossRefPubMed
5.
O'Neill TW, Roy DK: How many people develop fractures with what outcome?. Best Pract Res Clin Rheumatol. 2005, 19 (6): 879-895.CrossRefPubMed
6.
Johnell O, Kanis JA: An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006, 17 (12): 1726-1733.CrossRefPubMed
7.
Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B: The risk and burden of vertebral fractures in Sweden. Osteoporos Int. 2004, 15 (1): 20-26.CrossRefPubMed
8.
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA: Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999, 353 (9156): 878-882.CrossRefPubMed
9.
Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B: Mortality after osteoporotic fractures. Osteoporos Int. 2004, 15 (1): 38-42.CrossRefPubMed
10.
Iacovino JR: Mortality outcomes after osteoporotic fractures in men and women. J Insur Med. 2001, 33 (4): 316-320.PubMed
11.
Harrison RA, Siminoski K, Vethanayagam D, Majumdar SR: Osteoporosis-related kyphosis and impairments in pulmonary function: a systematic review. J Bone Miner Res. 2007, 22 (3): 447-457.CrossRefPubMed
12.
Yang HL, Zhao L, Liu J, Sanford CG, Chen L, Tang T, Ebraheim NA: Changes of pulmonary function for patients with osteoporotic vertebral compression fractures after kyphoplasty. J Spinal Disord Tech. 2007, 20: 221-225. United StatesCrossRefPubMed
13.
Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, et al: Risk of new vertebral fracture in the year following a fracture. JAMA. 2001, 285 (3): 320-323.CrossRefPubMed
14.
Leech JA, Dulberg C, Kellie S, Pattee L, Gay J: Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis. 1990, 141 (1): 68-71.CrossRefPubMed
15.
Culham EG, Jimenez HA, King CE: Thoracic kyphosis, rib mobility, and lung volumes in normal women and women with osteoporosis. Spine (Phila Pa 1976). 1994, 19 (11): 1250-1255.CrossRef
16.
Lombardi I, Oliveira LM, Mayer AF, Jardim JR, Natour J: Evaluation of pulmonary function and quality of life in women with osteoporosis. Osteoporos Int. 2005, 16 (10): 1247-1253.CrossRefPubMed
17.
Schlaich C, Minne HW, Bruckner T, Wagner G, Gebest HJ, Grunze M, Ziegler R, Leidig-Bruckner G: Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int. 1998, 8 (3): 261-267.CrossRefPubMed
18.
Wilsgaard T, Jacobsen BK, Mathiesen EB, Njølstad I: Weight loss and mortality: a gender-specific analysis of the Tromsø study. Gend Med. 2009, 6 (4): 575-586.CrossRefPubMed
19.
Eggen AE, Mathiesen EB, Wilsgaard T, Jacobsen BK, Njolstad I: The sixth survey of the Tromso Study (Tromso 6) in 2007–08: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey. Scand J Public Health. 2013, 41 (1): 65-80.CrossRefPubMed
20.
Melbye H, Amundsen K, Brox J, Eggen AE: The Association Between Self-Reported Symptoms of Recent Airway Infection and CRP Values in a General Population : The Tromso Study: Tromso 6. Inflammation. 2012, 35 (3): 1015-1022.CrossRefPubMed
21.
American Thoracic Society: Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995, 152 (3): 1107-1136.CrossRef
22.
Medbø A, Melbye H: Lung function testing in the elderly–can we still use FEV1/FVC < 70% as a criterion of COPD?. Respir Med. 2007, 101 (6): 1097-1105.CrossRefPubMed
23.
Kim N, Rowe BH, Raymond G, Jen H, Colman I, Jackson SA, Siminoski KG, Chahal AM, Folk D, Majumdar SR: Underreporting of vertebral fractures on routine chest radiography. AJR Am J Roentgenol. 2004, 182 (2): 297-300.CrossRefPubMed
24.
25.
Lenchik L, Rogers LF, Delmas PD, Genant HK: Diagnosis of osteoporotic vertebral fractures: importance of recognition and description by radiologists. AJR Am J Roentgenol. 2004, 183 (4): 949-958.CrossRefPubMed
26.
Waterloo S, Ahmed LA, Center JR, Eisman JA, Morseth B, Nguyen ND, Nguyen T, Sogaard AJ, Emaus N: Prevalence of vertebral fractures in women and men in the population-based Tromso Study. BMC Musculoskelet Disord. 2012, 13: 3-CrossRefPubMedPubMedCentral
27.
Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L: Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trondelag Study. Eur Respir J. 2001, 18 (5): 770-779.CrossRefPubMed
28.
Kjensli A, Ryg M, Falch JA, Armbrecht G, Diep LM, Eriksen EF, Ellingsen I: Does body height reduction influence interpretation of lung function in COPD patients?. Eur Respir J. 2010, 36 (3): 540-548.CrossRefPubMed
29.
Horie J, Murata S, Inoue Y, Nakamura S, Maeda Y, Matsumoto Y, Sannomiya T, Horikawa E: A Study of the Influence of the Pulmonary Function on the Angles of Thoracic Kyphosis and Lumbar Lordosis in Community-Dwelling Elderly Women. J Phys Ther Sci. 2009, 21 (2): 169-172.CrossRef
30.
Ho-Pham LT, Nguyen ND, Vu BQ, Pham HN, Nguyen TV: Prevalence and risk factors of radiographic vertebral fracture in postmenopausal Vietnamese women. Bone. 2009, 45 (2): 213-217.CrossRefPubMed
31.
32.
Middleton ET, Gardiner ED, Steel SA: Which women should be selected for vertebral fracture assessment? Comparing different methods of targeting VFA. Calcif Tissue Int. 2009, 85 (3): 203-210.CrossRefPubMed
33.
Ensrud KE, Schousboe JT: Clinical practice Vertebral fractures. N Engl J Med. 2011, 364 (17): 1634-1642.CrossRefPubMed
34.
Grigoryan M, Guermazi A, Roemer FW, Delmas PD, Genant HK: Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J. 2003, 12 (Suppl 2): S104-S112.CrossRefPubMedPubMedCentral
35.
Gregg EW, Pereira MA, Caspersen CJ: Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence. J Am Geriatr Soc. 2000, 48 (8): 883-893.CrossRefPubMed
36.
Gregg EW, Cauley JA, Seeley DG, Ensrud KE, Bauer DC: Physical activity and osteoporotic fracture risk in older women Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1998, 129 (2): 81-88.CrossRefPubMed
37.
Silman AJ, O'Neill TW, Cooper C, Kanis J, Felsenberg D: Influence of physical activity on vertebral deformity in men and women: results from the European Vertebral Osteoporosis Study. J Bone Miner Res. 1997, 12 (5): 813-819.CrossRefPubMed
38.
Chan HH, Lau EM, Woo J, Lin F, Sham A, Leung PC: Dietary calcium intake, physical activity and the risk of vertebral fracture in Chinese. Osteoporos Int. 1996, 6 (3): 228-232.CrossRefPubMed
39.
Greendale GA, Barrett-Connor E, Edelstein S, Ingles S, Haile R: Lifetime leisure exercise and osteoporosis The Rancho Bernardo study. Am J Epidemiol. 1995, 141 (10): 951-959.PubMed
40.
Aliverti A, Macklem PT: How and why exercise is impaired in COPD. Respiration. 2001, 68 (3): 229-239.CrossRefPubMed
41.
Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, et al: Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005, 20 (7): 1185-1194.CrossRefPubMed
42.
Wehren LE, Magaziner J: Hip fracture: risk factors and outcomes. Curr Osteoporos Rep. 2003, 1 (2): 78-85.CrossRefPubMed
43.
Delmas PD, Van Langerijt LD, Watts NB, Eastell R, Genant H, Grauer A, Cahall DL: Underdiagnosis of vertebral fractures is a worldwide problem: The IMPACT study. J Bone Miner Res. 2005, 20 (4): 557-563.CrossRefPubMed
44.
Papaioannou A, Parkinson W, Ferko N, Probyn L, Ioannidis G, Jurriaans E, Cox G, Cook RJ, Kumbhare D, Adachi JD: Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int. 2003, 14 (11): 913-917.CrossRefPubMed
45.
Kjensli A, Mowinckel P, Ryg MS, Falch JA: Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone. 2007, 40 (2): 493-497.CrossRefPubMed
46.
Dimai HP, Domej W, Leb G, Lau KH: Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia. J Bone Miner Res. 2001, 16 (11): 2132-2141.CrossRefPubMed
47.
Langhammer A, Forsmo S, Syversen U: Long-term therapy in COPD: any evidence of adverse effect on bone?. Int J Chron Obstruct Pulmon Dis. 2009, 4: 365-380.CrossRefPubMedPubMedCentral
48.
Jacobsen BK, Thelle DS: The Tromsø Heart Study: responders and non-responders to a health questionnaire, do they differ?. Scand J Soc Med. 1988, 16 (2): 101-104.PubMed
Metadata
Title
Cross-sectional associations between prevalent vertebral fracture and pulmonary function in the sixth Tromsø study
Authors
Bente Morseth
Hasse Melbye
Svanhild Waterloo
Marte R Thomassen
Marijke J Risberg
Nina Emaus
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2013
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/1471-2318-13-116

Other articles of this Issue 1/2013

BMC Geriatrics 1/2013 Go to the issue

Research article

Hope and connection: the experience of family caregivers of persons with dementia living in a long term care facility

Research article

The interRAI Acute Care instrument incorporated in an eHealth system for standardized and web-based geriatric assessment: strengths, weaknesses, opportunities and threats in the acute hospital setting

Research article

Association between ischemic stroke and migraine in elderly Chinese: a case–control study

Research article

The influence of ACE ID and ACTN3 R577X polymorphisms on lower-extremity function in older women in response to high-speed power training

Study protocol

Longitudinal evaluation of dementia care in German nursing homes: the “DemenzMonitor” study protocol

Research article

Improving dementia diagnosis and management in primary care: a cohort study of the impact of a training and support program on physician competency, practice patterns, and community linkages
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits